FDA-cleared profile

Aplio i900, Aplio i800 and Aplio i700 Software V8.1 Diagnostic Ultrasound System

Canon Medical Systems Corporation · Ultrasound · FDA-cleared (510(k))

Authorized purpose: Aplio i900, i800, and i700 software V8.1 are mobile diagnostic ultrasound systems for trained physicians or legally qualified users across multi-region diagnostic applications; on the Aplio i800/E3, the GF-UCT180 endoscopic ultrasound transducer also supports imaging of the upper gastrointestinal tract and surrounding organs.

Clinical role
Supports standard diagnostic ultrasound acquisition and review. V8.1 adds Left Atrial Appendage Analysis for user-specified dimensions and shape modeling, strain-ratio measurement, Mecha4D Ultra Wideview support, stored contrast-exam review, and specified endoscopic ultrasound imaging on the Aplio i800/E3.
Images and patients
Ultrasound · Multi-region
Key limitation
Keep in mind: When EUS transducer GF-UCT180 is connected, Aplio i800 Model TUS-AI800/E3 provides image information for diagnosis of the upper gastrointestinal tract and surrounding organs.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Aplio i900, i800, and i700 software V8.1 are mobile diagnostic ultrasound systems for trained physicians or legally qualified users across multi-region diagnostic applications; on the Aplio i800/E3, the GF-UCT180 endoscopic ultrasound transducer also supports imaging of the upper gastrointestinal tract and surrounding organs.
  • Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Multi-region Input: Ultrasound images and cine data acquired with compatible Aplio i900, i800, or i700 probes operating at approximately 2 to 33 MHz; the added endoscopic workflow uses the GF-UCT180 transducer on the Aplio i800/E3.
  • Who uses it?Intended users: Physicians or other legally qualified persons who have received appropriate training.
  • What does the software produce?Output: Diagnostic ultrasound images and measurements plus, where configured, left-atrial-appendage dimensions and shape models, strain ratios, wide-view Mecha4D images, stored contrast-exam displays, and upper-gastrointestinal endoscopic ultrasound images for qualified-user review.
  • What is its most important limitation?Key limitation: When EUS transducer GF-UCT180 is connected, Aplio i800 Model TUS-AI800/E3 provides image information for diagnosis of the upper gastrointestinal tract and surrounding organs.

Clinical takeaway. Clinical role: Aplio i900, i800, and i700 software V8.1 are mobile diagnostic ultrasound systems for trained physicians or legally qualified users across multi-region diagnostic applications; on the Aplio i800/E3, the GF-UCT180 endoscopic ultrasound transducer also supports imaging of the upper gastrointestinal tract and surrounding organs.

Evidence takeaway. Evidence from the reviewed source record: FDA-reviewed support combines manufacturer feature verification with a 10-case, single-cardiologist evaluation of Left Atrial Appendage Analysis. The summary does not report quantitative effect sizes, multisite testing, or patient outcomes.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Aplio i900, i800, and i700 software V8.1 are mobile diagnostic ultrasound systems for trained physicians or legally qualified users across multi-region diagnostic applications; on the Aplio i800/E3, the GF-UCT180 endoscopic ultrasound transducer also supports imaging of the upper gastrointestinal tract and surrounding organs.
  • Exact FDA submission
  • Checked 2026-09-19

Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.

Workflow role
Supports standard diagnostic ultrasound acquisition and review. V8.1 adds Left Atrial Appendage Analysis for user-specified dimensions and shape modeling, strain-ratio measurement, Mecha4D Ultra Wideview support, stored contrast-exam review, and specified endoscopic ultrasound imaging on the Aplio i800/E3.
  • Exact FDA submission
  • Checked 2026-09-02
Required input
Ultrasound images and cine data acquired with compatible Aplio i900, i800, or i700 probes operating at approximately 2 to 33 MHz; the added endoscopic workflow uses the GF-UCT180 transducer on the Aplio i800/E3.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Output and clinician action
Diagnostic ultrasound images and measurements plus, where configured, left-atrial-appendage dimensions and shape models, strain ratios, wide-view Mecha4D images, stored contrast-exam displays, and upper-gastrointestinal endoscopic ultrasound images for qualified-user review.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Care setting
Hospital and clinical environments performing diagnostic ultrasound; the specified Aplio i800/E3 configuration also supports endoscopic ultrasound workflows.
  • Exact FDA submission
  • Checked 2026-09-02
Intended users
Physicians or other legally qualified persons who have received appropriate training.
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Limitations
When EUS transducer GF-UCT180 is connected, Aplio i800 Model TUS-AI800/E3 provides image information for diagnosis of the upper gastrointestinal tract and surrounding organs.
  • Exact FDA submission
  • Checked 2026-09-19

The current value adds unreported validation and outcome limitations; this replacement preserves the exact configuration boundary stated by FDA.

Evidence summary
FDA-reviewed support combines manufacturer feature verification with a 10-case, single-cardiologist evaluation of Left Atrial Appendage Analysis. The summary does not report quantitative effect sizes, multisite testing, or patient outcomes.
  • Exact FDA submission
  • Checked 2026-09-02

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
FDA-reviewed support combines manufacturer feature verification with a 10-case, single-cardiologist evaluation of Left Atrial Appendage Analysis. The summary does not report quantitative effect sizes, multisite testing, or patient outcomes.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-02
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K233195 Left Atrial Appendage Analysis clinical evaluation

  • DesignManufacturer-sponsored evaluation by one cardiologist comparing the feature with the existing manual workflow
  • PopulationTen in-vivo left-atrial-appendage cine datasets; patient characteristics and acquisition sites were not reported
  • Scopeexact submission
  • Tested versionLeft Atrial Appendage Analysis on Aplio i900, i800, and i700 software V8.1
  • Samplen=10
  • IndependenceSponsor or vendor study

K233195

The evaluation confirmed workflow improvement and measurement usefulness for LAA-occlusion planning, but the summary provides no effect sizes, reader variability, or patient outcomes.

K233195 new-feature and integration testing

  • DesignManufacturer non-clinical feature verification using clinical datasets, elasticity phantoms, scan-range testing, and transducer integration testing
  • PopulationLeft-atrial-appendage data, elasticity phantoms, Mecha4D scan-range data, and the Aplio i800/E3 with GF-UCT180 transducer
  • Scopeexact submission
  • Tested versionAplio i900, i800, and i700 software V8.1
  • IndependenceSponsor or vendor study

K233195

Regulatory verification evidence; it does not establish comparative clinical outcomes or local-site performance.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Ultrasound images and cine data acquired with compatible Aplio i900, i800, or i700 probes operating at approximately 2 to 33 MHz; the added endoscopic workflow uses the GF-UCT180 transducer on the Aplio i800/E3.

    Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-19 · FDA K233195: Aplio i900, Aplio i800 and Aplio i700 Software V8.1 Diagnostic Ultrasound System

  2. Routing

    Source context, not route validation: The system is an on-premises ultrasound platform with site-network image exchange. Canon's current interoperability page lists an IHE integration statement for Aplio i700, i800, and i900 software V6.0 or later, covering V8.1.

    Scope: Exact product version. Confirm the installed IHE statement, DICOM services, endoscopic-video workflow, network routing, and downstream object support.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-02 · FDA K233195: Aplio i900, Aplio i800 and Aplio i700 Software V8.1 Diagnostic Ultrasound System · IHE integration statements for current Canon ultrasound products

  3. AI processing

    Source context, not route validation: On-premises mobile Aplio i900, i800, or i700 ultrasound console running software V8.1; the added endoscopic ultrasound workflow requires the Aplio i800/E3 and GF-UCT180 transducer.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-02 · FDA K233195: Aplio i900, Aplio i800 and Aplio i700 Software V8.1 Diagnostic Ultrasound System

  4. Returned objects

    Source context, not route validation: Diagnostic ultrasound images and measurements plus, where configured, left-atrial-appendage dimensions and shape models, strain ratios, wide-view Mecha4D images, stored contrast-exam displays, and upper-gastrointestinal endoscopic ultrasound images for qualified-user review.

    Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-19 · FDA K233195: Aplio i900, Aplio i800 and Aplio i700 Software V8.1 Diagnostic Ultrasound System

  5. Viewer/worklist/report

    Unresolved route: Diagnostic ultrasound images and measurements plus, where configured, left-atrial-appendage dimensions and shape models, strain ratios, wide-view Mecha4D images, stored contrast-exam displays, and upper-gastrointestinal endoscopic ultrasound images for qualified-user review.

    Scope: Exact FDA submission. Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-19 · FDA K233195: Aplio i900, Aplio i800 and Aplio i700 Software V8.1 Diagnostic Ultrasound System

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
On-premises mobile Aplio i900, i800, or i700 ultrasound console running software V8.1; the added endoscopic ultrasound workflow requires the Aplio i800/E3 and GF-UCT180 transducer.
  • Exact FDA submission
  • Checked 2026-09-02
Integration
The system is an on-premises ultrasound platform with site-network image exchange. Canon's current interoperability page lists an IHE integration statement for Aplio i700, i800, and i900 software V6.0 or later, covering V8.1.
  • Exact product version
  • Checked 2026-09-02

Confirm the installed IHE statement, DICOM services, endoscopic-video workflow, network routing, and downstream object support.

Security
Canon Medical's cybersecurity page states that Canon imaging systems follow a software development life cycle governed by the NIST 800-53 Risk Management Framework adhering to Defense Health Agency certification requirements; FIPS 140-2 certified cipher standards; deny-all firewall configuration and near-real-time SIEM syslog export as premium offerings; a dedicated cybersecurity risk management team for threat intelligence monitoring, advisories and incident response; and published OS and third-party update policies. Vendor statement; no certification or test report was read.
  • Vendor-wide
  • Checked 2026-10-26

Vendor statement, not an attestation. Identity bridge: the page is on us.medical.canon, Canon Medical's own site (Canon Medical Systems USA), and describes Canon Medical imaging devices generally; the FDA applicant is Canon Medical Systems Corporation, named in the corporate name-change press release on the same domain. Regional page with general device claims; exact-release scope is not established.

V8.1 feature package

Adds Left Atrial Appendage Analysis, strain-ratio measurement, Mecha4D Ultra Wideview support, and a viewer for stored contrast-exam images.

exact submission · checked 2026-09-02

Confirm licensed options, user-editing behavior, output objects, and report transfer for the purchased configuration.

Endoscopic ultrasound configuration

The GF-UCT180 transducer is integrated exclusively with the Aplio i800 TUS-AI800/E3 configuration for imaging the upper gastrointestinal tract and surrounding organs.

exact submission · checked 2026-09-02

Verify the exact console variant, transducer, endoscope compatibility, reprocessing workflow, accessories, and staff training.

IHE integration documentation

Canon's current interoperability page lists an IHE integration statement for Aplio i700, i800, and i900 software V6.0 or later.

exact product version · checked 2026-09-02

Obtain and test the statement corresponding to the exact installed software build.

Deployment model

Mobile, on-premises diagnostic ultrasound console; endoscopic imaging requires the specified i800/E3 configuration and transducer.

exact submission · checked 2026-09-02

Site preparation, cybersecurity controls, service access, updates, training, and downtime planning require current vendor documentation.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K233195
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

The exact device name, classification, and indications identify a diagnostic ultrasound system; the current dossier has no modality value. Controlled directory display reconciled from exact FDA wording: Diagnostic ultrasound. -> Ultrasound.

Anatomy
Multi-region
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2024-01-24
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
22Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, fda device recall, vendor interoperability, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-10-27 - Exact FDA submission

    No public price or quote for the exact K233195 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "Canon Aplio reimbursement CPT Medicare"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-10-27 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-10-27 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

7 sources - 3 history items

Source ledger

  1. FDA K233195: Aplio i900, Aplio i800 and Aplio i700 Software V8.1 Diagnostic Ultrasound System

    U.S. Food and Drug Administration - Published 2024-01-24 - Accessed 2026-09-19

    Scope: purpose, anatomy, intendedUsers, input, output, modality, limitations, evidenceSummary, clinicalUse

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  6. IHE integration statements for current Canon ultrasound products

    Canon Medical Systems Corporation - Accessed 2026-09-02

    Scope: integration, implementationCapabilities

  7. Canon Medical: Medical Imaging Cybersecurity

    Canon Medical Systems USA - Accessed 2026-10-26

    Scope: security

Research history

  1. K233195 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K252074

Aplio i900, Aplio i800 and Aplio i700 Software V9.0 Diagnostic Ultrasound System

Canon Medical Systems Corporation

Authorized purpose: Aplio i900, i800, and i700 software V9.0 are mobile diagnostic ultrasound systems for multi-region imaging. K252074 adds deep-learning 3rd Harmonic Imaging for abdominal images; with specified endoscopic transducers, the Aplio i800/E3 also supports imaging of the upper gastrointestinal tract, surrounding organs, airways, tracheobronchial tree, and esophagus.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-10-31
FDA-cleared K251963

LOGIQ E10s

Ge Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: LOGIQ E10s is a general-purpose diagnostic ultrasound system supporting the labeled adult, pediatric, cardiac, vascular, abdominal, obstetric, small-organ, musculoskeletal, urologic, and procedural applications.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-10-29
FDA-cleared K251985

LOGIQ E10

Ge Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: LOGIQ E10 is a general diagnostic ultrasound system for qualified users across fetal and obstetric, abdominal, gynecologic, pediatric, small-organ, breast, cardiac, vascular, musculoskeletal, urologic, transrectal, transvaginal, transesophageal, and intraoperative applications.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-10-29

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history